Oya, M., Ito, T., Sato, M., Morita, M., Kajita, M., & Nonomura, N. Avelumab + axitinib treatment in older patients with advanced renal cell carcinoma in Japan: Subgroup analyses of post‐marketing surveillance data by age. Wiley.
Chicago Style (17th ed.) CitationOya, Mototsugu, Taito Ito, Masashi Sato, Makiko Morita, Masahiro Kajita, and Norio Nonomura. Avelumab + Axitinib Treatment in Older Patients with Advanced Renal Cell Carcinoma in Japan: Subgroup Analyses of Post‐marketing Surveillance Data by Age. Wiley.
MLA (9th ed.) CitationOya, Mototsugu, et al. Avelumab + Axitinib Treatment in Older Patients with Advanced Renal Cell Carcinoma in Japan: Subgroup Analyses of Post‐marketing Surveillance Data by Age. Wiley.
Warning: These citations may not always be 100% accurate.